The EpiShuttle was used in a simulation exercise organized by the Organization for the Prohibition of Chemical Weapons as a tool for strengthening national preparedness for CBRN events.
EpiShuttle’s first time in Japan! EpiGuard attended DSEI in Tokio and had a demonstration in Kyoto. Read more about it in the blog!
Today’s modern society is under constant threat of being exposed to dangerous CBRN agents. This blog will dive deep into CBRN to answer the questions: What does CBRN stand for? What are the types of CBRN agents? How dangerous are they for society? What do to in case of CBRN event?
Webinar speakers were three experts in the field of medical transportation. They shared their knowledge about transporting patients with the EpiShuttle in the public healthcare and the private air ambulance sectors.
EpiGuard is proud to announce that the EpiShuttle has been approved by the Therapeutic Goods Administration (TGA) and is now available for use in the Australian market!
EpiGuard’s commitment to safety and quality was attested by our successful completion of an audit by the Norwegian Medicines Agency last June.
It’s been an exciting summer at EpiGuard, with the launch of our new e-Learning platform and the appointment of our new CEO, Michael Eimstad.
Be prepared for next Disease X! EpiShuttle e-learning will make patient isolation and transportation safer and more efficient!
Meet EpiGuard heroes – three brave men on the front line helping people of Ukraine.
Finland is investing in the future safety of their citizens by increasing national preparedness for pandemics and CBRNe events with EpiShuttles!
